ARROWHEAD PHARMACEUTICALS, INC. Marketable Securities (Non-Current)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Marketable Securities (Non-Current) of $17.81 million as of 2014-12-31, per its 10-Q filed 2015-02-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net › Long-Term Investments
us-gaap:MarketableSecuritiesNoncurrent · last filed 2015-02-09
- 2014-12-31: Marketable Securities, Noncurrent $17.81M.
- 2014-09-30: Marketable Securities, Noncurrent $23.09M.
- 2014-06-30: Marketable Securities, Noncurrent $26.28M.
- 2014-03-31: Marketable Securities, Noncurrent $34.05M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2014-12-31 | $17.81M 10-Q · filed 2015-02-09 |
| 2014-09-30 | $23.09M 10-Q · filed 2015-02-09 |
| 2014-06-30 | $26.28M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $34.05M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $9.84M 10-Q · filed 2014-02-04 |
| 2013-09-30 | $1.70M 10-K · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |